Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
Titel:
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
Auteur:
Wolfe, Cameron R Tomashek, Kay M Patterson, Thomas F Gomez, Carlos A Marconi, Vincent C Jain, Mamta K Yang, Otto O Paules, Catharine I Palacios, Guillermo M Ruiz Grossberg, Robert Harkins, Michelle S Mularski, Richard A Erdmann, Nathaniel Sandkovsky, Uriel Almasri, Eyad Pineda, Justino Regalado Dretler, Alexandra W de Castilla, Diego Lopez Branche, Angela R Park, Pauline K Mehta, Aneesh K Short, William R McLellan, Susan L F Kline, Susan Iovine, Nicole M El Sahly, Hana M Doernberg, Sarah B Oh, Myoung-don Huprikar, Nikhil Hohmann, Elizabeth Kelley, Colleen F Holodniy, Mark Kim, Eu Suk Sweeney, Daniel A Finberg, Robert W Grimes, Kevin A Maves, Ryan C Ko, Emily R Engemann, John J Taylor, Barbara S Ponce, Philip O Larson, LuAnn Melendez, Dante Paolo Seibert, Allan M Rouphael, Nadine G Strebe, Joslyn Clark, Jesse L Julian, Kathleen G de Leon, Alfredo Ponce Cardoso, Anabela de Bono, Stephanie Atmar, Robert L Ganesan, Anuradha Ferreira, Jennifer L Green, Michelle Makowski, Mat Bonnett, Tyler Beresnev, Tatiana Ghazaryan, Varduhi Dempsey, Walla Nayak, Seema U Dodd, Lori E Beigel, John H Kalil, Andre C